Advisory Services Network’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-40
Closed -$37 2345
2023
Q4
$37 Buy
+40
New +$30 ﹤0.01% 3822
2023
Q2
Sell
-2,040
Closed -$2.57K 2328
2023
Q1
$2.57K Buy
2,040
+2,000
+5,000% +$3.83K ﹤0.01% 3367
2022
Q4
$87 Buy
+40
New +$329 ﹤0.01% 3916
2021
Q3
Sell
-40
Closed 2152
2021
Q2
$0 Buy
+40
New +$347 ﹤0.01% 3613
2021
Q1
Sell
-40
Closed 1969
2020
Q4
$0 Sell
40
-500
-93% -$4.92K ﹤0.01% 3449
2020
Q3
$7K Buy
+540
New +$7.16K ﹤0.01% 2622

Other funds holding GOSS

Advisory Services Network's GOSS Position: Q1 2024 in Review

Advisory Services Network sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 40 shares — an estimated $37 sold.

Advisory Services Network first reported a position in GOSS in Q3 2020 and held it in 6 quarters. The position peaked at $7K in Q3 2020. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • Advisory Services Network reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 40 Gossamer Bio shares in Q1 2024, an estimated $37.
  • Advisory Services Network first reported a position in Gossamer Bio in Q3 2020 and held it in 6 quarters.
  • Advisory Services Network's Gossamer Bio position peaked at $7K in Q3 2020.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.